VTRS Viatris Inc

USD 12.06 -0.20 (-1.63%)
As of 12:02PM EST.

N/A

Average User
Rating
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis

USD 12.26

+0.10 (+0.82)%

USD 14.42B

9.32M

USD 13.60(+10.93%)

N/A

Icon

VTRS

Viatris Inc (USD)
COMMON STOCK | NSD
USD 12.06
-0.20 (-1.63%)
As of 12:02PM EST.

N/A

Average User
Rating
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis

USD 14.42B

N/A

USD 12.26

Viatris Inc Stock Forecast

USD 13.60
(+10.93%)

Based on the Viatris Inc stock forecasts from 8 analysts, the average analyst target price for Viatris Inc is USD 13.60 over the next 12 months. Viatris Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Viatris Inc is Slightly Bearish, which is based on 7 positive signals and 9 negative signals. At the last closing, Viatris Inc’s stock price was USD 12.26. Viatris Inc’s stock price has changed by +5.33% over the past week, +10.15% over the past month and -18.65% over the last year.

No recent analyst target price found for Viatris Inc
No recent average analyst rating found for Viatris Inc

Company Overview

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredien...Read More

https://www.viatris.com

1000 Mylan Boulevard, Canonsburg, PA, United States, 15317

37,000

December

USD

USA

Adjusted Closing Price

Loading...

Technical Indicators

  • 1.17

  • USD 14.97

  • 2.36

  • USD 8.33

  • 22,202,673

  • USD 10.52

  • 20,160,727

  • USD 11.28

  • 0.29%

  • 2.06%

  • 77.26%

  • 4.12%

Unadjusted Closing Price

Loading...

Assets

Top Holdings

Top Sectors

Top Regions

Share Volume

Loading...

Relative Performance

Security Capital Gain Dividend Return Total Return
Loading...

Stocks Similar To Viatris Inc (Sector: Drug Manufacturers-Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
PPD
PPD Inc 0.00 (0.00%) USD16.61B 47.04 21.58
NBIX
Neurocrine Biosciences Inc -0.71 (-0.64%) USD10.41B 180.48 98.51
MYL
Mylan N.V 0.00 (0.00%) USD8.59B 30.73 11.86
APHA
Tilray, Inc 0.00 (0.00%) USD6.86B 60.60 454.68
MNTA
Momenta Pharmaceuticals, Inc 0.00 (0.00%) USD6.24B N/A N/A
ALKS
Alkermes Plc +0.05 (+0.17%) USD4.73B N/A -72.85
ITCI
Intracellular Th -0.10 (-0.21%) USD4.45B N/A -14.58
LNTH
Lantheus Holdings Inc +1.14 (+1.98%) USD3.86B 36.91 16.96
EVO
Evotec SE ADR +0.10 (+1.03%) USD3.66B 508.00 -19.09
HCM
HUTCHMED DRC +0.73 (+4.05%) USD3.64B 17.69 -6.38

ETFs Containing VTRS

Symbol Name Weight Mer Price(Change) Market Cap
IHE
iShares U.S. Pharmaceutic.. 4.79 % 0.39 % +0.82 (+0.44%) USD0.41B
XPH
SPDR® S&P Pharmaceutical.. 4.51 % 0.35 % +0.27 (+0.62%) USD0.21B
FTXH
First Trust Nasdaq Pharma.. 4.39 % 0.60 % +0.09 (+0.33%) USD0.04B
DVLU
First Trust Dorsey Wright.. 2.76 % 0.60 % +0.20 (+0.82%) USD0.02B
PILL
Direxion Daily Pharmaceut.. 2.74 % 0.97 % +0.21 (+1.98%) USD0.01B
SPDV
AAM S&P 500 High Dividend.. 2.15 % 0.29 % +0.10 (+0.31%) USD0.08B
FXH
First Trust Health Care A.. 2.12 % 0.61 % +1.28 (+1.14%) USD1.66B
RNMC
First Trust Mid Cap US Eq.. 0.98 % 0.60 % +0.38 (+1.30%) USD0.01B
DON
WisdomTree U.S. MidCap Di.. 0.88 % 0.38 % +0.41 (+0.92%) USD3.45B

Frequently Asked Questions About VTRS Stock

Based on ratings from 8 analysts Viatris Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 4 buy, sell and 4 hold ratings.

VTRS stock's dividend yield is 4.12%. Our analysis grades VTRS stock's dividend yield at C. This means that VTRS stock's dividend yield is above 75% of the stocks in the Drug Manufacturers-Specialty & Generic sector in the NSD exchange. Based on this VTRS may be a average dividend stock for its sector.

Based on targets from 8 analysts, the average taret price for VTRS is USD 13.60 over the next 12 months. The maximum analyst target price is USD 16 while the minimum anlayst target price is USD 10.

VTRS stock's Price/Earning ratio is 18.02. Our analysis grades VTRS stock's Price / Earning ratio at F. This means that VTRS stock's Price/Earning ratio is above 51% of the stocks in the Drug Manufacturers-Specialty & Generic sector in the NSD exchange. Based on this VTRS may be a overvalued for its sector.

The last closing price of VTRS's stock was USD 12.26.

The most recent market capitalization for VTRS is USD 14.42B.

Based on targets from 8 analysts, the average taret price for VTRS is projected at USD 13.60 over the next 12 months. This means that VTRS's stock price may go up by +10.93% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...